While integrating operational technology (OT) with information technology (IT) drives efficiency and innovation, it also ...

This balancing act between strategic initiatives and daily security demands underscores the importance of prioritization.

The FDA last year turned away the companies' application and asked for additional efficacy data. Regeneron and Sanofi said the resubmission adds results from an additional Phase 3 study of Dupixent in ...

Spire plans to use the sale proceeds to fully pay off its outstanding debt and invest in growth opportunities.

Looking forward, we continue to be optimistic about the long-term outlook of the Fund's portfolio, which trades at 12.7 times ...

Alex Chriss, President and CEO, PayPal Paul Hudson, Chief Executive Officer, Sanofi In conversation with: Kristin Stoller, ...